Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia
Closed
Other
This study is open to people who are newly diagnosed with B cell or T cell acute lymphoblastic leukaemia (ALL) and haven’t started treatment. It is a sub study of the original UKALL14 trial.
In particular, it is for
adults between 25 and 65 years old with B cell or T cell acute lymphoblastic leukaemia
and for people between 19 and 65 who have ALL with the Philadelphia chromosome.
Cancer Research UK supports this study.
Recruitment start: 1 December 2017
Recruitment end: 29 October 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Adele Fielding
Cancer Research UK
NIHR Clinical Research Network: Cancer
Novartis
Roche
CRUK & UCL Cancer Trials Centre
Chugai Pharma UK Ltd
Biovitrum
Sigma Tau
Baxalta
Last reviewed: 6 January 2022
CRUK internal database number: 15400